Improve Medical Instruments Co Ltd
SZSE:300030
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
CN |
I
|
Improve Medical Instruments Co Ltd
SZSE:300030
|
1.4B CNY | 2.5 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
222.9B USD | 5.8 | ||
US |
Danaher Corp
NYSE:DHR
|
194.6B USD | 4.7 | ||
US |
Agilent Technologies Inc
NYSE:A
|
44.1B USD | 6.7 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.8B USD | 3.5 | ||
CH |
Lonza Group AG
SIX:LONN
|
37B CHF | 5.6 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
53.4T KRW | 13.4 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
31.6B USD | 8.8 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.5B USD | 3.6 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
24.2B USD | 8.1 | ||
US |
Waters Corp
NYSE:WAT
|
20B USD | 7.4 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.